Sadhana Nitro Chem Limited AI Stock Analysis
Want to see IN:SADHNANIQ full AI Analyst Report?
Sadhana Nitro Chem Limited (SADHNANIQ) AI Stock Analysis
Sadhana Nitro Chem Limited
(NSE:SADHNANIQ)
The score is driven primarily by weak financial performance, including a sharp 2026 revenue decline, deeply negative profitability, and sustained cash burn, only partially offset by improved leverage. Technicals add downside pressure with the price below key moving averages and negative MACD, while valuation offers limited support due to a negative P/E and only a modest dividend yield.
Sadhana Nitro Chem Limited (SADHNANIQ) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 7.37B
- Dividend Yield
- 1.10%
- Average Volume (3M)
- 487.53K
- Price to Earnings (P/E)
- -1.7
- Beta (1Y)
- 1.00
- Revenue Growth
- -24.31%
- EPS Growth
- -473.28%
- Country
- India
- Employees
- 190
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Sadhana Nitro Chem Limited Business Overview & Revenue Model
Company Description
Sadhana Nitro Chem Ltd. specializes in the production and supply of a diverse array of chemical products, including intermediates, heavy organic compounds, and high-performance chemicals. Additionally, the company provides wireless network equipment...
Sadhana Nitro Chem Limited Financial Statement Overview
Summary
Financial results are severely pressured by the latest annual period (2026): revenue fell ~58%, margins turned deeply negative, and the company posted a large net loss. Cash flow is also weak with operating cash flow and free cash flow negative and worsening in 2026, indicating ongoing cash burn. The main positive is improved leverage (debt-to-equity ~0.25), but profitability and cash generation have not stabilized.
Income Statement
18Very NegativeBalance Sheet
52NeutralCash Flow
24Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 888.40M | 496.70M | 1.66B | 1.89B | 1.42B | 1.30B |
| Gross Profit | 20.70M | -423.80M | 1.03B | 983.25M | 689.31M | 548.97M |
| EBITDA | -267.30M | -445.00M | 441.90M | 445.34M | 211.63M | 175.08M |
| Net Income | -579.40M | -864.20M | 75.60M | 40.82M | 31.78M | 62.25M |
Balance Sheet | ||||||
| Total Assets | 6.70B | 6.58B | 6.37B | 5.32B | 4.26B | 3.86B |
| Cash, Cash Equivalents and Short-Term Investments | 52.40M | 137.71M | 112.10M | 60.52M | 70.95M | 129.67M |
| Total Debt | 688.90M | 1.13B | 2.47B | 2.33B | 1.39B | 1.16B |
| Total Liabilities | 2.02B | 2.03B | 3.56B | 3.05B | 2.00B | 2.26B |
| Stockholders Equity | 4.68B | 4.54B | 2.81B | 2.27B | 2.26B | 1.60B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -1.33B | -457.10M | -685.02M | -861.17M | -457.73M |
| Operating Cash Flow | 0 | -688.80M | 478.70M | -23.82M | -378.15M | -47.02M |
| Investing Cash Flow | 0 | -470.60M | -885.60M | -648.60M | -527.80M | -388.15M |
| Financing Cash Flow | 0 | 1.34B | 246.70M | 411.80M | 716.39M | 455.27M |
Sadhana Nitro Chem Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SADHNANIQ, the sentiment is Positive. The current price of 2.57 is above the 20-day moving average (MA) of 2.26, above the 50-day MA of 2.54, and above the 200-day MA of 2.36, indicating a bullish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 58.65 is Neutral, neither overbought nor oversold. The STOCH value of 86.02 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:SADHNANIQ.
Sadhana Nitro Chem Limited Peers Comparison
Overall Rating
IN:ALKYLAMINE65Neutral
IN:BALAMINES58Neutral
IN:NEOGEN50Neutral
IN:BODALCHEM47Neutral
IN:LXCHEM46Neutral
IN:SADHNANIQ43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 65Neutral | INR 82.57B | 33.28 | ― | 0.62% | 13.38% | 35.82% | |
| 58Neutral | INR 59.05B | 25.45 | ― | 0.59% | 20.91% | 62.44% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 50Neutral | INR 83.35B | 191.31 | ― | 0.04% | 26.66% | 51.16% | |
| 47Neutral | INR 20.27B | 14.20 | ― | ― | 44.89% | 306.54% | |
| 46Neutral | INR 45.90B | 26.46 | ― | 0.18% | 21.34% | 105.39% | |
| 43Neutral | INR 7.43B | -1.66 | ― | 1.10% | -24.31% | -473.28% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:SADHNANIQ | Sadhana Nitro Chem Limited | 2.57 | 0.71 | 37.88% | |
| IN:ALKYLAMINE | Alkyl Amines Chemicals Limited | 1608.65 | -154.90 | -8.78% | |
| IN:BALAMINES | Balaji Amines Limited | 1865.65 | 642.01 | 52.47% | |
| IN:BODALCHEM | Bodal Chemicals Limited | 162.60 | 104.93 | 181.95% | |
| IN:LXCHEM | Laxmi Organic Industries Ltd. | 163.95 | -23.68 | -12.62% | |
| IN:NEOGEN | Neogen Chemicals Ltd. | 2856.90 | 1640.29 | 134.82% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 15, 2026
